Misook Yu

Array ( [id] => 6730042 [patent_doc_number] => 20030186232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/993966 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21694 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186232.pdf [firstpage_image] =>[orig_patent_app_number] => 09993966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921750 [patent_doc_number] => 20020115148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Compositions and methods for diagnosing or treating psoriasis' [patent_app_type] => new [patent_app_number] => 09/994365 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27980 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115148.pdf [firstpage_image] =>[orig_patent_app_number] => 09994365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467532 [patent_doc_number] => 07235522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration' [patent_app_type] => utility [patent_app_number] => 09/988150 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3745 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235522.pdf [firstpage_image] =>[orig_patent_app_number] => 09988150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157722 [patent_doc_number] => 20020146768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Apo-2LI and Apo-3 polypeptides' [patent_app_type] => new [patent_app_number] => 09/993234 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24185 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146768.pdf [firstpage_image] =>[orig_patent_app_number] => 09993234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1130040 [patent_doc_number] => 06787326 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Interaction between the VHL tumor suppressor and hypoxia inducible factor, and assay methods relating thereto' [patent_app_type] => B1 [patent_app_number] => 09/959873 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17932 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787326.pdf [firstpage_image] =>[orig_patent_app_number] => 09959873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405616 [patent_doc_number] => 20020182619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer' [patent_app_type] => new [patent_app_number] => 10/035415 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60974 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182619.pdf [firstpage_image] =>[orig_patent_app_number] => 10035415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653948 [patent_doc_number] => 20030009017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => '38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof' [patent_app_type] => new [patent_app_number] => 10/012140 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 64271 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009017.pdf [firstpage_image] =>[orig_patent_app_number] => 10012140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6540500 [patent_doc_number] => 20020193569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Bispecific fusion protein and method of use for enhancing effector cell killing of target cells' [patent_app_type] => new [patent_app_number] => 09/986174 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9348 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193569.pdf [firstpage_image] =>[orig_patent_app_number] => 09986174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536393 [patent_doc_number] => 20020137109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)' [patent_app_type] => new [patent_app_number] => 10/015728 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17800 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137109.pdf [firstpage_image] =>[orig_patent_app_number] => 10015728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528226 [patent_doc_number] => 20020192777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Testis protein, Zsig86' [patent_app_type] => new [patent_app_number] => 10/000639 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192777.pdf [firstpage_image] =>[orig_patent_app_number] => 10000639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606570 [patent_doc_number] => 07153935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Tumor suppressor gene' [patent_app_type] => utility [patent_app_number] => 10/045815 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 15483 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153935.pdf [firstpage_image] =>[orig_patent_app_number] => 10045815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172101 [patent_doc_number] => 20050203036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Compositions and methods for treating hematologic malignancies and multiple drug resistance' [patent_app_type] => utility [patent_app_number] => 10/007255 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17591 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203036.pdf [firstpage_image] =>[orig_patent_app_number] => 10007255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790482 [patent_doc_number] => 06984502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-10 [patent_title] => 'Methods and compositions of human 69087 nucleic acids and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/044205 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 46124 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984502.pdf [firstpage_image] =>[orig_patent_app_number] => 10044205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750291 [patent_doc_number] => 20030044811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'EST-defined probe for cancer progression' [patent_app_type] => new [patent_app_number] => 10/051769 [patent_app_country] => US [patent_app_date] => 2001-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5720 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044811.pdf [firstpage_image] =>[orig_patent_app_number] => 10051769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1305870 [patent_doc_number] => 06617121 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Snail, new tumoral progression marker and target protein of new antitumoral compounds' [patent_app_type] => B1 [patent_app_number] => 09/806445 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5058 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617121.pdf [firstpage_image] =>[orig_patent_app_number] => 09806445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015013 [patent_doc_number] => 20020102264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Uses of monoclonal antibody 8H9' [patent_app_type] => new [patent_app_number] => 09/982645 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 55664 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102264.pdf [firstpage_image] =>[orig_patent_app_number] => 09982645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715810 [patent_doc_number] => 20030027158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides' [patent_app_type] => new [patent_app_number] => 09/977418 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 55613 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027158.pdf [firstpage_image] =>[orig_patent_app_number] => 09977418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935445 [patent_doc_number] => 20020061308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Bcl-2 gene proteins conjugated to a ligand for a cell surface antigen of a specific cell type' [patent_app_type] => new [patent_app_number] => 09/974338 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1740 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061308.pdf [firstpage_image] =>[orig_patent_app_number] => 09974338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627208 [patent_doc_number] => 20020086361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Modulators of antiestrogen pharmacology' [patent_app_type] => new [patent_app_number] => 09/972032 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10023 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086361.pdf [firstpage_image] =>[orig_patent_app_number] => 09972032 [rel_patent_id] =>[rel_patent_doc_number] =>)